How Close Are We to a Vaccine for Ebola?

How Close Are We to a Vaccine for Ebola? Play

Sept. 2 (Bloomberg) –- Bloomberg Intelligence’s Sam Fazeli discusses the latest on the ebola virus outbreak in West Africa as U.S. scientists begin enrolling patients in safety trials for GlaxoSmithKline’s experimental vaccine. He speaks to Anna Edwards and Mark Barton on “Countdown.” (Source: Bloomberg)

blog comments powered by Disqus